Sanara MedTech Inc.
SMTI
$31.64
-$0.08-0.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 86.67M | 78.06M | 72.41M | 68.00M | 64.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.67M | 78.06M | 72.41M | 68.00M | 64.99M |
| Cost of Revenue | 8.14M | 7.68M | 7.44M | 7.62M | 7.85M |
| Gross Profit | 78.53M | 70.38M | 64.97M | 60.39M | 57.14M |
| SG&A Expenses | 74.30M | 68.75M | 64.06M | 60.22M | 56.99M |
| Depreciation & Amortization | 4.42M | 4.41M | 4.30M | 4.00M | 3.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.56M | 84.78M | 79.37M | 75.60M | 72.65M |
| Operating Income | -5.89M | -6.72M | -6.96M | -7.59M | -7.67M |
| Income Before Tax | -9.91M | -8.47M | -6.69M | -5.02M | -4.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.91 | -8.47 | -6.69 | -5.02 | -4.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 247.40K | 110.70K | 120.00K | 133.20K | 136.70K |
| Net Income | -9.66M | -8.36M | -6.57M | -4.89M | -4.30M |
| EBIT | -5.89M | -6.72M | -6.96M | -7.59M | -7.67M |
| EBITDA | -1.48M | -2.31M | -2.66M | -3.59M | -3.99M |
| EPS Basic | -1.14 | -0.99 | -0.78 | -0.59 | -0.52 |
| Normalized Basic EPS | -0.64 | -0.64 | -0.61 | -0.61 | -0.60 |
| EPS Diluted | -1.14 | -0.99 | -0.78 | -0.59 | -0.52 |
| Normalized Diluted EPS | -0.64 | -0.64 | -0.61 | -0.61 | -0.60 |
| Average Basic Shares Outstanding | 33.94M | 33.79M | 33.60M | 33.36M | 33.11M |
| Average Diluted Shares Outstanding | 33.94M | 33.79M | 33.60M | 33.36M | 33.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |